If you could vote on Brexit now which option would you choose?

GSK, Regeneron Covid Antibody Drugs Unlikely to Work for Omicron, WHO Says

The antibody drugs GSK Plc and Regeneron Pharmaceuticals Inc. developed against Covid don’t appear to work for omicron and its subvariants, a panel of experts advising the World Health Organization said, recommending against the use of the medicines. The group’s decision comes amid “evidence from laboratory studies that these drugs are not likely to work against currently circulating variants,” the panel said in the medical journal BMJ Friday.

Bloomberg - September 18, 2022

View the full story here: https://www.bloomberg.com/news/articles/2022-09-15/who-panel-advises-against-gsk-regeneron-antibodies-for-covid